Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against The Gap, Inc. (“Gap” or the “Company”) (NYSE: GPS) in the United States District Court of the Eastern District of New York on behalf of all persons and entities who purchased or otherwise acquired Gap securities between November 24, 2021 and July 11, 2022, both dates inclusive (the “Class Period”). Investors have until February 3, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Click here to participate in the action.

According to the Complaint, the Company made false and misleading statements to the market. Gap suffered from significant management errors in its Old Navy brand, specifically related to the "BODEQUALITY" program which impacted its financial results. BODEQUALITY caused inventory risks to grow, despite the Company's claims to investors. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Gap, investors suffered damages.

If you purchased or otherwise acquired Gap shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at investigations@bespc.com, telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221214005984/en/